Professional Seasonal Analysis for Trading

Molecular Pharmacology (USA), Ltd. (MLPH)

Seasonality Analysis

Stocks 17 Years Analyzed

Molecular Pharmacology (USA), Ltd. Annual Seasonality Statistics

236.51%
Avg Annual Return
29.7%
Avg Monthly Win Rate
8/12
Positive Months
17
Years Analyzed

Molecular Pharmacology (USA), Ltd. Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 26.22%
41%
Weak
February -7.32%
6%
Very Weak
March BEST 80.74%
53%
Moderate
April 31.18%
24%
Weak
May 30.17%
38%
Weak
June WORST -15.51%
13%
Very Weak
July 14.29%
41%
Weak
August -12.19%
24%
Very Weak
September 35.03%
35%
Weak
October 3.49%
41%
Weak
November -4.28%
24%
Very Weak
December 54.70%
18%
Weak

Molecular Pharmacology (USA), Ltd. 2026 vs Historical Pattern

Current Position
0
Historical Avg Position
24.58
Deviation
-24.58
Performance
Significantly Below Average

Molecular Pharmacology (USA), Ltd. Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for MLPH with overlay patterns, custom date ranges, and more.

Create Free Account

Molecular Pharmacology (USA), Ltd. Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Molecular Pharmacology (USA), Ltd. Seasonal Historical Performance

Historical Performance

See historical average returns for MLPH across multiple timeframes.

Create Free Account

About Molecular Pharmacology (USA), Ltd. (MLPH) Seasonality

Molecular Pharmacology (USA), Ltd. (MLPH) has been analyzed using 17 years of historical data to identify seasonal patterns. Classified under Stocks, Molecular Pharmacology (USA), Ltd. shows distinct seasonal tendencies based on historical data.

The strongest month for Molecular Pharmacology (USA), Ltd. is historically March, with an average return of 80.74% and a win rate of 53%. Conversely, June tends to be the weakest month, averaging -15.51% return.

Looking at the full calendar year, Molecular Pharmacology (USA), Ltd. has an average annual return of 236.51% with an overall monthly win rate of 29.7%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Molecular Pharmacology (USA), Ltd. has a consistency score of 45.1 (Poor), based on 18 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Molecular Pharmacology (USA), Ltd. Seasonality FAQ

What is the best month to buy Molecular Pharmacology (USA), Ltd. (MLPH)?

Historically, March has been the best month for Molecular Pharmacology (USA), Ltd., with an average return of 80.74% and a win rate of 53%. However, past performance does not guarantee future results.

What is the worst month for Molecular Pharmacology (USA), Ltd. (MLPH)?

Based on historical data, June has been the weakest month for Molecular Pharmacology (USA), Ltd., with an average return of -15.51%. This is a historical observation and does not guarantee future results.

How reliable is MLPH seasonality data?

The seasonality analysis for Molecular Pharmacology (USA), Ltd. is based on 17 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Molecular Pharmacology (USA), Ltd. seasonality in my trading?

Use Molecular Pharmacology (USA), Ltd. (MLPH) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.